Canada Pension Plan Investment Board’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-407,000	Closed	-$15.3M	–	1447
2021 Q1	$15.3M	Buy	+407,000	New	+$10.1M	0.02%	455
2018 Q1	–	Sell	-316,500	Closed	-$6.94M	–	1313
2017 Q4	$6.94M	Hold	316,500	–	–	0.01%	620
2017 Q3	$12.9M	Hold	316,500	–	–	0.03%	454
2017 Q2	$9.53M	Hold	316,500	–	–	0.02%	507
2017 Q1	$11.4M	Hold	316,500	–	–	0.03%	422
2016 Q4	$15.9M	Sell	316,500 -158,300	-33%	-$8.32M	0.06%	252
2016 Q3	$24.9M	Sell	474,800 -28,200	-6%	-$1.35M	0.09%	171
2016 Q2	$20.8M	Hold	503,000	–	–	0.08%	192
2016 Q1	$20.4M	Hold	503,000	–	–	0.08%	202
2015 Q4	$20.9M	Buy	+503,000	New	+$16.9M	0.1%	160

Canada Pension Plan Investment Board's FPRX Position: Q2 2021 in Review

Canada Pension Plan Investment Board sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 407,000 shares — an estimated $15.3M sold.

Canada Pension Plan Investment Board first reported a position in FPRX in Q4 2015 and held it in 10 quarters. The position peaked at $24.9M in Q3 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Canada Pension Plan Investment Board reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Canada Pension Plan Investment Board sold 407,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $15.3M.
Canada Pension Plan Investment Board first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 10 quarters.
Canada Pension Plan Investment Board's Five Prime Therapeutics, Inc. position peaked at $24.9M in Q3 2016.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2021, filed 16 Aug 2021.